GleamWall
中文EN

ELTP ELITE PHARMACEUTICALS INC /NV/

Pharmaceutical Preparations · OTC · SEC CIK 1053369 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY17.8%
TTM net income YoY333.0%
TTM EPS YoY50.0%
Revenue 3-yr CAGR52.2%
Net income 3-yr CAGR50.1%

Margins

Gross margin43.7%
Operating margin25.3%
Net margin41.6%
FCF margin6.0%
EBITDA margin26.1%

Returns

ROE65.6%
ROA46.1%
ROIC (approx.)52.7%
Asset turnover1.11x

Leverage & solvency

Liabilities / assets15.3%
Debt / equity0.00x
Current ratio6.65x
Interest coverage338.18x

Cash quality & payout

Operating cash flow / net income0.18x
Accruals ratio37.8%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue$148.87M$84.04M
Cost of revenue$73.85M$43.96M
Gross profit$75.02M$40.09M
R&D expense$5.74M$7.96M
SG&A expense$17.60M$9.00M
Operating income$49.11M$19.60M
Interest expense$111,361$128,234
Pretax income$56.81M-$52,140
Income tax$11.94M$4.26M
Net income$44.87M-$4.31M
EBITDA$50.18M$20.83M
EPS (basic)0.040.00
EPS (diluted)0.030.00
Weighted avg. shares (diluted)1.14B1.07B
Balance sheet
Cash & equivalents$29.80M$11.77M
Receivables$59.72M$29.21M
Inventory$21.26M$16.24M
Current assets$112.11M$57.74M
PP&E, net$10.18M$10.33M
Intangibles$4.79M$5.64M
Total assets$138.29M$96.39M
Current liabilities$17.39M$11.84M
Total liabilities$39.41M$42.87M
Shareholders' equity$98.88M$53.52M
Shares outstanding1.08B1.07B
Cash flow statement
Operating cash flow$23.75M$7.46M
Capital expenditure$925,626$1.63M
Free cash flow$22.82M$5.83M
Investing cash flow-$925,626-$2.40M
Financing cash flow-$4.32M-$825,740
Depreciation & amortization$1.07M$1.23M
Stock-based compensation$176,507$227,565

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.